FTV vs ZYME · P/E 31, rev $6.23B vs rev $76.3M
Fortive Corp (FTV) versus Zymeworks Inc. Common Stock (ZYME) — a side-by-side from cached financials, not a winner call.
Fortive Corp (FTV) is a scientific & technical instruments company listed on US.
Zymeworks Inc. Common Stock (ZYME) is a biotechnology company listed on NASDAQ.
Latest reported FTV revenue for 2024-12-31 was $6.23B. Net income was $832.9M. Revenue was up 2.7% from 2023-12-31 to 2024-12-31. FTV currently screens at market cap $24.34B and trailing P/E 31.4.
Latest reported ZYME revenue for 2024-12-31 was $76.3M. Net income was -$122.7M. Revenue was up 0.4% from 2023-12-31 to 2024-12-31. ZYME currently screens at market cap $1.68B.
FTV currently screens at market cap $24.34B and trailing P/E 31.4. ZYME currently screens at market cap $1.68B.
Not investment advice. Open the FTV and ZYME stock pages for the full models.
Not investment advice.